Genome Editing Market Size, Share, CAGR of 16.9%, Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Genome Editing Market Size Analysis

Global Genome Editing Market Introduction
By Technology
1. Introduction
  1. Technology By Value
2. CRISPR
  1. By Value
3. TALEN
  1. By Value
4. ZFN
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cell Line Engineering
  1. By Value
3. Animal Genetic Engineering
  1. By Value
4. Plant Genetic Engineering
  1. By Value
5. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academics and Government Research Institutes
  1. By Value
4. Contract Research Organizations
  1. By Value
5. Other End Users
  1. By Value

North America Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. CRISPR
  1. By Value
3. TALEN
  1. By Value
4. ZFN
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cell Line Engineering
  1. By Value
3. Animal Genetic Engineering
  1. By Value
4. Plant Genetic Engineering
  1. By Value
5. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academics and Government Research Institutes
  1. By Value
4. Contract Research Organizations
  1. By Value
5. Other End Users
  1. By Value
U.S.
1. By Technology
  1. Introduction
    1. Technology By Value
  2. CRISPR
    1. By Value
  3. TALEN
    1. By Value
  4. ZFN
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Cell Line Engineering
    1. By Value
  3. Animal Genetic Engineering
    1. By Value
  4. Plant Genetic Engineering
    1. By Value
  5. Other Applications
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotechnology Companies
    1. By Value
  3. Academics and Government Research Institutes
    1. By Value
  4. Contract Research Organizations
    1. By Value
  5. Other End Users
    1. By Value
Canada

Europe Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. CRISPR
  1. By Value
3. TALEN
  1. By Value
4. ZFN
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cell Line Engineering
  1. By Value
3. Animal Genetic Engineering
  1. By Value
4. Plant Genetic Engineering
  1. By Value
5. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academics and Government Research Institutes
  1. By Value
4. Contract Research Organizations
  1. By Value
5. Other End Users
  1. By Value
U.K.
1. By Technology
  1. Introduction
    1. Technology By Value
  2. CRISPR
    1. By Value
  3. TALEN
    1. By Value
  4. ZFN
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Cell Line Engineering
    1. By Value
  3. Animal Genetic Engineering
    1. By Value
  4. Plant Genetic Engineering
    1. By Value
  5. Other Applications
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotechnology Companies
    1. By Value
  3. Academics and Government Research Institutes
    1. By Value
  4. Contract Research Organizations
    1. By Value
  5. Other End Users
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. CRISPR
  1. By Value
3. TALEN
  1. By Value
4. ZFN
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cell Line Engineering
  1. By Value
3. Animal Genetic Engineering
  1. By Value
4. Plant Genetic Engineering
  1. By Value
5. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academics and Government Research Institutes
  1. By Value
4. Contract Research Organizations
  1. By Value
5. Other End Users
  1. By Value
China
1. By Technology
  1. Introduction
    1. Technology By Value
  2. CRISPR
    1. By Value
  3. TALEN
    1. By Value
  4. ZFN
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Cell Line Engineering
    1. By Value
  3. Animal Genetic Engineering
    1. By Value
  4. Plant Genetic Engineering
    1. By Value
  5. Other Applications
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotechnology Companies
    1. By Value
  3. Academics and Government Research Institutes
    1. By Value
  4. Contract Research Organizations
    1. By Value
  5. Other End Users
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. CRISPR
  1. By Value
3. TALEN
  1. By Value
4. ZFN
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cell Line Engineering
  1. By Value
3. Animal Genetic Engineering
  1. By Value
4. Plant Genetic Engineering
  1. By Value
5. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academics and Government Research Institutes
  1. By Value
4. Contract Research Organizations
  1. By Value
5. Other End Users
  1. By Value
UAE
1. By Technology
  1. Introduction
    1. Technology By Value
  2. CRISPR
    1. By Value
  3. TALEN
    1. By Value
  4. ZFN
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Cell Line Engineering
    1. By Value
  3. Animal Genetic Engineering
    1. By Value
  4. Plant Genetic Engineering
    1. By Value
  5. Other Applications
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotechnology Companies
    1. By Value
  3. Academics and Government Research Institutes
    1. By Value
  4. Contract Research Organizations
    1. By Value
  5. Other End Users
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. CRISPR
  1. By Value
3. TALEN
  1. By Value
4. ZFN
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cell Line Engineering
  1. By Value
3. Animal Genetic Engineering
  1. By Value
4. Plant Genetic Engineering
  1. By Value
5. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academics and Government Research Institutes
  1. By Value
4. Contract Research Organizations
  1. By Value
5. Other End Users
  1. By Value
Brazil
1. By Technology
  1. Introduction
    1. Technology By Value
  2. CRISPR
    1. By Value
  3. TALEN
    1. By Value
  4. ZFN
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Cell Line Engineering
    1. By Value
  3. Animal Genetic Engineering
    1. By Value
  4. Plant Genetic Engineering
    1. By Value
  5. Other Applications
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotechnology Companies
    1. By Value
  3. Academics and Government Research Institutes
    1. By Value
  4. Contract Research Organizations
    1. By Value
  5. Other End Users
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Genome Editing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Merck KGaA
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
GenScript
Sangamo Therapeutics
Lonza
Editas Medicine
CRISPR Therapeutic
Tecan Trading AG
Precision Biosciences
PerkinElmer Inc
Cellectis S.A
Genome Medical, Inc
BioMed Central Ltd
Aevi Genomic Medicine, Inc
Congenica Ltd
Deep Genomics
Illumina, Inc
Thermo Fisher Scientific Inc
QIAGEN N.V
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment